Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin. | [Pakistan Journal of Medical Sciences • 2014]

Author(s):

1. Wenbin Liu: Department of Hematology, First Clinical Medical School of Zhejiang Chinese Medicine University, China

2. Zhiping Hu: Department of Hematology, First Clinical Medical School of Zhejiang Chinese Medicine University, China

3. Shengyun Lin: Department of Hematology, First Clinical Medical School of Zhejiang Chinese Medicine University, China

4. Jianghua He: Department of Hematology, First Clinical Medical School of Zhejiang Chinese Medicine University, China

5. Yuhong Zhou: Department of Hematology, First Clinical Medical School of Zhejiang Chinese Medicine University, China

Abstract:

Hematologic disorders are very common in Systmic lupus erythematosus (SLE).First presentation of SLE with severe aplastic anemia (SAA) is extremely rare. We report a patient with the diagnosis of secondary SAA associated with SLE. Conventional therapy was not effective. She received Rituximab (RTX) and Antithymocyte globulin (ATG) therapy, her response was satisfactory finally. Her hematologic parameters were within normal ranges until last follow-up, eight months and six months after therapy was initiated with RTX and ATG, respectively. This is the first time RTX and ATG were successfully used in the treatment of SAA secondary to SLE.

Page(s): 449-451

DOI: DOI not available

Published: Journal: Pakistan Journal of Medical Sciences, Volume: 30, Issue: 2, Year: 2014

Keywords:

Keywords are not available for this article.

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views